{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T10:41:59Z","timestamp":1696156919713},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.humimm.2011.12.013","type":"journal-article","created":{"date-parts":[[2011,12,27]],"date-time":"2011-12-27T18:13:55Z","timestamp":1325009635000},"page":"278-281","source":"Crossref","is-referenced-by-count":5,"title":["High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup"],"prefix":"10.1016","volume":"73","author":[{"given":"Elpiniki","family":"Kritikou-Griva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Spyropoulou-Vlachou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos J.","family":"Tsagarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Goumakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Vrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Galanopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanos I.","family":"Papadhimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Androutsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Paterakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Stavropoulos-Giokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2011.12.013_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hoc.2010.02.009","article-title":"Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success","volume":"24","author":"Sloand","year":"2010","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"10.1016\/j.humimm.2011.12.013_bib2","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1182\/blood.V98.13.3513","article-title":"Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH\/aplastic anemia syndrome","volume":"98","author":"Maciejewski","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.12.013_bib3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.V100.5.1570.h81702001570_1570_1574","article-title":"HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome","volume":"100","author":"Saunthararajah","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.12.013_bib4","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1182\/blood-2005-05-1958","article-title":"Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence","volume":"107","author":"Battiwalla","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.12.013_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0198-8859(00)00115-4","article-title":"MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data","volume":"61","author":"Papassavas","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2011.12.013_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humimm.2011.12.013_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.2448875","article-title":"Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase","volume":"239","author":"Saiki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.humimm.2011.12.013_bib8","first-page":"467","article-title":"Genetic polymorphisms associated with the development and clinical course of multiple sclerosis (review)","volume":"28","author":"Kallaur","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.humimm.2011.12.013_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","article-title":"Type 1 diabetes: etiology, immunology, and therapeutic strategies","volume":"91","author":"van Belle","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.humimm.2011.12.013_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2009.12.009","article-title":"The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis","volume":"35","author":"Tob\u00f3n","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.humimm.2011.12.013_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2008.11.005","article-title":"HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis","volume":"8","author":"Duarte-Rey","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.humimm.2011.12.013_bib12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/rheumatology\/39.10.1060","article-title":"HLA association with autoimmune disease: a failure to protect?","volume":"39","author":"Zanelli","year":"2000","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.humimm.2011.12.013_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00002281-199709000-00003","article-title":"Autoantibodies in systemic lupus erythematosus","volume":"9","author":"Cabral","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.humimm.2011.12.013_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11899-008-0005-y","article-title":"Immunosuppressive therapy for myelodysplastic syndromes: refining the indications","volume":"3","author":"Barrett","year":"2008","journal-title":"Curr Hematol Malignancy Rep"},{"key":"10.1016\/j.humimm.2011.12.013_bib15","first-page":"296","article-title":"Association of HLA DRB1 polymorphism with susceptibility to myelodysplastic syndrome and aplastic anemia in Chinese Han population","volume":"28","author":"Huo","year":"2011","journal-title":"Chin J Med Genet"},{"key":"10.1016\/j.humimm.2011.12.013_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood.V100.1.22","article-title":"HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria","volume":"100","author":"Shichishima","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.12.013_bib17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2011.194","article-title":"Targeting immune dysregulation in myelodysplastic syndromes","volume":"305","author":"Olnes","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.humimm.2011.12.013_bib18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0198-8859(03)00163-0","article-title":"HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women","volume":"64","author":"Cervantes","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2011.12.013_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.humimm.2004.01.016","article-title":"HLA-DRB1 alleles and HLA-DRB1 shared epitopes are markers for juvenile rheumatoid arthritis subgroups in Colombian mestizos","volume":"65","author":"Garavito","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2011.12.013_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00296-001-0139-x","article-title":"HLA-DRB1 antigens in Taiwanese patients with juvenile-onset systemic lupus erythematosus","volume":"21","author":"Huang","year":"2001","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.humimm.2011.12.013_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/00016489309135866","article-title":"HLA associations with Meni\u00e8re's disease","volume":"113","author":"Koyama","year":"1993","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.humimm.2011.12.013_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s002770100360","article-title":"Immunosuppressive therapy for patients with refractory anemia","volume":"80","author":"Asano","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humimm.2011.12.013_bib23","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ctrv.2007.07.005","article-title":"Current treatment strategies in low-risk myelodysplastic syndromes","volume":"33","author":"Giagounidis","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.humimm.2011.12.013_bib24","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood-2002-11-3325","article-title":"A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome","volume":"102","author":"Saunthararajah","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.12.013_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1399-0039.2004.00327.x","article-title":"An update of the HLA genomic region, locus information and disease associations","volume":"2004","author":"Shiina","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2011.12.013_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.seminhematol.2007.11.006","article-title":"The role of the immune system in myelodysplasia: implications for therapy","volume":"45","author":"Sloand","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.humimm.2011.12.013_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0002-9440(10)62277-8","article-title":"Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes","volume":"166","author":"Campioni","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humimm.2011.12.013_bib28","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V99.5.1594","article-title":"In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis","volume":"99","author":"Claessens","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2011.12.013_bib29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-0609.2005.00551.x","article-title":"Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis","volume":"75","author":"Stifter","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.humimm.2011.12.013_bib30","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3109\/10428194.2011.584002","article-title":"Myelodysplastic syndromes: the role of the immune system in pathogenesis","volume":"52","author":"Warlick","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humimm.2011.12.013_bib31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1046\/j.1365-2141.1998.00920.x","article-title":"Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles","volume":"102","author":"Molldrem","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humimm.2011.12.013_bib32","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2010-04-277921","article-title":"T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy","volume":"117","author":"Sloand","year":"2011","journal-title":"Blood"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885911006045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885911006045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T11:39:09Z","timestamp":1593430749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885911006045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0198885911006045"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2011.12.013","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}